Table 2.
GWAS datasets.
| Dataset | Disease | Source (accession no.) |
Ref. | Cases (F/M ratio) |
Controls (F/M ratio) |
|---|---|---|---|---|---|
| ALS Finland | Amyotrophic Lateral Sclerosis (ALS) | dbGaP (phs000344) | [17] | 400 (1.02) |
490 (3.76) |
| ALS Irish | Amyotrophic Lateral Sclerosis (ALS) | dbGaP (phs000127) | [18] | 221 (0.86) |
210 (0.87) |
| Celiac disease CIDR | Celiac disease | dbGaP (phs000274) | [19] | 1576 (2.52) |
504 (1.24) |
| MS Case Control | Multiple Sclerosis (MS) | dbGaP (phs000171) | [20] | 943 (2.02) |
851 (1.93) |
| MS WT2 | Multiple Sclerosis (MS) | WT2 | [21] | 2666 (2.82) |
1389 (0.98) |
| Vitiligo GWAS1 | Vitiligo | dbgaP (phs000224) | [22] | 1391 (2.38) |
4521* (1.28) |
| Vitiligo GWAS2 | Vitiligo | - | [23] | 415 (1.88) |
2552* (1.62) |
| CD NIDDK | Chron's disease (CD) | dbGaP (phs000130) | [24] | 791 (1.09) |
922 (1.02) |
| CDWT1 | Crohn’s disease (CD) | WT1 | [25] | 1592 (1.62) |
1701 (0.84) |
| Psoriasis CASP | Psoriasis | dbGaP (phs000019) | [26] | 1209 (1.06) |
1271 (1.17) |
| T2D GENEVA | Type-2 Diabetes (T2D) | dbGaP (phs000091) | [27] | 2515 (1.39) |
2850 (1.40) |
| T2D WT1 | Type-2 Diabetes (T2D) | WT1 | [25] | 1811 (0.72) |
1668 (1.35) |
| T1D WT1 | Type-1 Diabetes (T1D) | WT1 | [25] | 1867 (0.96) |
1714 (0.82) |
| RA WT1 | Rheumatoid Arthritis (RA) | WT1 | [25] | 1772 (3.00) |
1709 (0.86) |
| AS WT2 | Ankylosing Spondylitis (AS) | WT2 | [28] | 1472 (0.51) |
1260 (0.89) |
| UC WT2 | Ulcerative Colitis (UC) | WT2 | [29] | 2341 (1.04) |
1699 (1.01) |